aerva persica/抗真菌藥

BACKGROUND Liver diseases, the fifth most common cause of global death, can be metabolic, toxin-induced, or infective. Though approximately 35 Saudi medicinal plants are traditionally used to treat liver disorders, the hepatoprotective potential of Aerva javanica has not been explored. OBJECTIVE To

Aerva javanica and Paeonia emodi plants extracts were studied for antibacterial activity against Escherichia coli (NCTC 10418), Klebsiella pneumoniae (ATCC 700603), Pseudomonas aeruginosa, Staphylococcus aureus, Salmonella typhi, Staphylococcus epidermidis (NCTC 11047) and Methicillin Resistant

Nutraceuticals provide health benefits beyond their basic nutrition by modulating a number of biochemical pathways. They are derived from natural products and have gained recognition worldwide as an adjuvant or therapy in the treatment of metabolic disorders such as diabetes. Although the regulation

The Aerva plants are exceptionally rich in phytochemicals and possess therapeutics potential. Phytochemical screening shows that Aerva persica (Burm.f.) Merr. contains highest contents i.e., total phenolics, flavonoids, flavonols, tannins, alkaloids, carbohydrates, anthraquinones and glycosides.

BACKGROUND Diabetes is the leading cause of morbidity and mortality, with a number currently diagnosed as high as 371 million. Plant-based therapy could be an ideal choice because of fewer side-effects and wider acceptability. Hence, the antihyperglycemic potential of Aerva lanata, a herb prescribed

BACKGROUND Ethnopharmacological studies are important for the discovery of new drugs from reported indigenous flora. The current study was aimed to document medicinal flora and its therapeutic actions along with the relative importance in local health care system of the district of Vehari, Punjab